Stock Analysis on Net

Boston Scientific Corp. (NYSE:BSX)

$22.49

This company has been moved to the archive! The financial data has not been updated since May 4, 2023.

Current Ratio
since 2005

Microsoft Excel

Paying user area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Calculation

Boston Scientific Corp., current ratio, long-term trends, calculation

Microsoft Excel

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1 US$ in millions


Current Assets
From 2005 to 2022, current assets experienced significant fluctuations. Initially, there was a substantial increase from 2,631 million USD in 2005 to a peak of 5,921 million USD in 2007. Following this peak, current assets declined steadily until 2012, reaching around 3,022 million USD. From 2013 onwards, there was a gradual recovery observed, with a sharp rise evident in 2020 to 6,694 million USD. Subsequently, current assets slightly decreased but remained elevated above levels seen during the early 2010s, standing at 5,760 million USD in 2022.
Current Liabilities
Current liabilities showed an overall increasing trend during the period. Starting at 1,479 million USD in 2005, they rose markedly to 3,233 million USD by 2008 and fluctuated around this range until 2011. After 2011, liabilities sharply increased, peaking at 5,654 million USD in 2016. A decline followed, reaching 3,681 million USD in 2020. More recent years showed a moderate increase again, with liabilities measured at 3,803 million USD in 2022.
Current Ratio
The current ratio, a key liquidity indicator, demonstrated varied dynamics over the years. It began at a healthy level of 1.78 in 2005, slightly improving to around 1.86 in 2006 and maintaining above 1.6 until 2008. The ratio then declined sharply, hitting a low of 0.68 in 2016, indicating potential liquidity pressures. After this low point, a recovery was evident, with the ratio climbing back to 1.82 in 2020, suggesting improved short-term financial stability. The ratio slightly moderated in the last two years but remained around 1.5, consistent with a generally sound liquidity position.
Summary Insights
Overall, liquidity conditions showed pronounced variability aligned with both rising and falling trends in current assets and current liabilities. The period from 2011 to 2016 stands out due to deteriorated liquidity, driven by rising liabilities and relatively stagnant or declining current assets. The subsequent recovery in current ratio indicates successful measures to strengthen liquidity, supported by increased current assets and reduced liabilities in recent years. The latest data points suggest a stable liquidity environment with adequate short-term resources relative to obligations.

Comparison to Competitors

Boston Scientific Corp., current ratio, long-term trends, comparison to competitors

Microsoft Excel

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).


Comparison to Sector (Health Care Equipment & Services)

Boston Scientific Corp., current ratio, long-term trends, comparison to sector (health care equipment & services)

Microsoft Excel

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).


Comparison to Industry (Health Care)

Boston Scientific Corp., current ratio, long-term trends, comparison to industry (health care)

Microsoft Excel

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).